Skip to main content
Profile picture for Jeffrey Curtis, MD, MS, MPH

Jeffrey Curtis, MD, MS, MPH

Jeffrey R. Curtis, MD, MS, MPH is a Professor of Medicine at the University of Alabama, Birmingham. He is also the Co-Director of the UAB Center for Education and Research on Therapeutics (CERTs) of Musculoskeletal Disorders, which has a major emphasis on evaluating the safety and comparative effectiveness of medications for rheumatic diseases. Additionally, as the Director of the UAB Arthritis Clinical Intervention Program, he leads the clinical trials unit for the rheumatology division at UAB, with a particular focus on rheumatoid arthritis and psoriatic arthritis. He is the Co-Director of the UAB Pharmacoepidemiology and Pharmacoeconomics Research (PEER) Unit. PEER uses multiple large data sources to study comparative effectiveness questions across multiple chronic diseases. These data sources include national administrative data from Medicare and commercial health plans, electronic health record data, and large registries. He has been awarded the William J. Koopman Endowed Professorship in Rheumatology and Immunology. The evaluation of the efficacy, comparative effectiveness, and safety of the medications used to treat RA and spondyloarthritis are among Dr. Curtis’s research interests. He also studies risk factors for and outcomes of osteoporosis. 

Articles By Jeffrey Curtis, MD, MS, MPH

vaccination.jpg

Vaccination with Shingrix: Does it work for patients on JAKi?

Dr. Jeffrey Curtis examines abstracts #1997 and #0452 presented at the ACR 2020 annual meeting.

Read Article

Why T2T is Too Risky for Some Patients

My colleagues indulged me in a small experiment. I set before them $100 in cash and offered each of them a choice: take the $100, or flip a coin for a 50% chance to win a certain amount of money that they could specify. They would tell me the minimum amount of money I needed to offer in order to prefer the coin flip over taking the $100. What does this have to do with treat-to-target?

Read Article
×